SIMPLIFY YOUR LABORATORY EXPERIENCE
Gold Standard Diagnostics provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu and outstanding customer service, we solve real laboratory problems.
Featured Content

Look inside Oculus

ASSAYS

Our extensive assay menu meets the needs of any laboratory.

Learn More >>

INSTRUMENTS

An innovative suite of instruments will increase quality and consistency for your lab.

Learn More >>

SERVICES

We know diagnostics and have you covered from technical support to product development.

Learn More >>

DISTRIBUTORS

GSD offers cost-effective laboratory automation solutions for sale around the globe.

Learn More >>

CLINICAL LABORATORIES

GSD provides a total solution that improves laboratory efficiency while reducing costs.

Learn More >>

MANUFACTURERS

Sell your diagnostic products to the large U.S. clinical laboratory market.

Learn More >>

NEWS

April 25, 2019

GOLD STANDARD DIAGNOSTICS CORP. ANNOUNCES ISSUANCE OF U.S. PATENT FOR THE AIX1000® SYSTEM

Gold Standard Diagnostics Corp., announced today that the United States Patent and Trademark Office has issued U.S. Patent No. 10,222,375 covering the company’s AIX1000 system.

Read More

December 20, 2018

THE SOFTWARE ENGINEERS AT GOLD STANDARD DIAGNOSTICS (GSD) HAVE JUST RELEASED THE MOST INTUITIVE AND FUNCTIONAL MEDICAL DIAGNOSTIC DEVICE SOFTWARE ON THE MARKET- STORM SOFTWARE SUITE VERSION 2.0.

Created specifically for Gold Standard Diagnostics’ open instrumentation platforms, the Storm Software Suite supports multiple testing technologies and formats.

Read More

July 5, 2018

GOLD STANDARD DIAGNOSTICS ACHIEVES RECORD GROWTH WITH THE AIX1000™ SYSTEM WITH ITS RPR ASSAY, A SYPHILIS TESTING METHOD

With more than 13 million Rapid Plasma Reagin assay tests performed, the AIX1000 is now the industry standard in syphilis serology screening

Read More
EVENTS

SEACM 2022

Read More

APHL Annual Conference

Read More

Categories

All CategoriesAutoimmuneCardiovascularEndocrinologyInfectious DiseaseCovid-19